Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,137
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 11,541–11,560 of 17,335 recalls

FDA Recall Terminated Historical recordClass II

Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-001-24

by Claris Lifesciences Inc

Reason
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ciprofloxacin in Dextrose (5%) Injection, USP, 400 mg in 200 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-009-24

by Claris Lifesciences Inc

Reason
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sensodyne Repair & Protect Whitening, (stannous fluoride 0.45% (0.15% w/v fluoride ion)), Net Wt. 3.4 oz, Distributed by Glaxo SmithKline Consumer Healthcare LP Moon Township PA 15108 --- NDC 0135-0575-01, UPC UPC: 3 10158 84060 2

by GSK Consumer Healthcare

Reason
Presence of Foreign Substance; low concentration of an additional flavoring ingredient, Patchouli oil resulting in complaints of off flavor/scent
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20

by Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 80 mg*, packaged in a) 90-count bottles (NDC 0378-3953-09) and b) 500-count bottles (NDC 0378-3953-07), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

by Mylan Pharmaceuticals Inc.

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 40 mg*, packaged in a) 90-count bottles (NDC 0378-3952-09) and b) 500-count bottles (NDC 0378-3952-07); Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

by Mylan Pharmaceuticals Inc.

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 20 mg*, packaged in a) 90-count bottles (NDC 0378-3951-09) and b) 500-count bottles (NDC 0378-3951-07); Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

by Mylan Pharmaceuticals Inc.

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 10 mg*, packaged in a) 90-count bottles (NDC 0378-3950-77); b) 90-count bottles (NDC 0378-3950-09); c) 500-count bottles (NDC 0378-3950-05); d) 500-count bottles (NDC 0378-3950-07), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

by Mylan Pharmaceuticals Inc.

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01) and b) 500 count (NDC 68382-033-05) bottles, Rx only, manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ

by Zydus Pharmaceuticals USA Inc

Reason
Failed Dissolution Specifications; 9 month long term stability
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-048-24

by Claris Lifesciences Inc

Reason
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fluconazole Injection, USP, 400 mg in 200 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-003-06

by Claris Lifesciences Inc

Reason
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Grace Kennedy Foods USA LLC

Product
La Fe Papa Criollas Yellow Potato Net Wt. 14 oz. Distribute…
Reason
La Fe Papas Criollos may be contaminated with Listeria Monoctyogenes.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Give and Go Prepared Foods Corp - Finch

Product
The Bakery Mini Pecan Tarts Part Platter NET WT 16x 16.2 OZ…
Reason
Dried weevil larvae may be present in the recalled products.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Give and Go Prepared Foods Corp - Finch

Product
Two-Bite Pecan Tarts Party Platter 16 x 16.2 (460g) item num…
Reason
Dried weevil larvae may be present in the recalled products.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Give and Go Prepared Foods Corp - Finch

Product
Two-Bite Turtle Brownie Party Platter 16 x 12.2 oz (346g) it…
Reason
Dried weevil larvae may be present in the recalled products.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

Give and Go Prepared Foods Corp - Finch

Product
Two-Bite Pecan Tart 9.2 oz (261g) item number 02023; NL Two-…
Reason
Dried weevil larvae may be present in the recalled products.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Desonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0309-60

by Fougera Pharmaceuticals Inc.

Reason
Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream
Published
March 29, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Testosterone Cypionate Injection , USP, 200 mg/mL, 1 mL vial , For Intramuscular Use Only, Rx Only, Distributed by Sun Pharma Ind. Inc., NJ 08512, Manufactured by Sun Pharma Ind. Ltd. India, NDC 62756-015-40

by Sun Pharmaceutical Industries, Inc.

Reason
Presence of Particulate Matter
Published
March 29, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-307-13

by AVKARE Inc.

Reason
Failed impurities/ degradation specifications: Product was above specification for unknown impurities.
Published
March 29, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 900 mg/180 mL (25mg/5mL), Rx Only, Distributed by: NextWave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc, New York, NY 10017 Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852 (NDC 24478-190-30).

by PFIZER INC

Reason
Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.
Published
March 29, 2017
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.